HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antimicrobial therapy of urinary tract infections in children.

Abstract
The main objectives in childhood urinary tract infections are rapid recovery from complaints, prevention of urosepsis and infection-related complications as well as the prevention of renal parenchymal damage. Calculated antibiotic therapy should take the local resistance rates of uropathogens into consideration. The current situation of bacterial resistances differs from region to region. In Escherichia coli, resistance rates against cephalosporins, aminoglycosides, nitrofurantoin und chinolones have been relatively low. In contrast, resistance rates against ampicillin have increased over the last 20 years. A similar trend has been observed for TMP/SMX. The choice of appropriate antibiotics, the duration of therapy and the form of application depend on age, severity of clinical symptoms and the presence of complicating factors. In early infancy, a combination of aminoglycoside/ampicillin or ceftazidime/ampicillin is commonly recommended as first-line treatment in pyelonephritis. Pyelonephritis in young infants should always be treated in a paediatric clinic. In later infancy and childhood, an oral third-generation cephalosporin can be used.
AuthorsRolf Beetz, Martin Westenfelder
JournalInternational journal of antimicrobial agents (Int J Antimicrob Agents) Vol. 38 Suppl Pg. 42-50 (Dec 2011) ISSN: 1872-7913 [Electronic] Netherlands
PMID22036250 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2011. Published by Elsevier B.V.
Chemical References
  • Anti-Bacterial Agents
Topics
  • Anti-Bacterial Agents (therapeutic use)
  • Bacteria (drug effects)
  • Bacterial Infections (drug therapy)
  • Child
  • Child, Preschool
  • Drug Resistance, Bacterial
  • Drug Therapy, Combination (methods)
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Urinary Tract Infections (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: